Haregewein Assefa
Impact in
- Virology top 10%
- HIV Research and Treatment
-
- Computational Drug Discovery Methods
Papers in
-
- Natural product bioactivities and synthesis 2
-
- HIV/AIDS drug development and treatment 2
- Co-authors
- John K. Buolamwini (4 shared papers)Shantaram Kamath (2 shared papers)Robert D. Sindelar (2 shared papers)Larry Walker (2 shared papers)Alison Nimrod (2 shared papers)Jarosław Sławiński (1 shared paper)Nouri Neamati (1 shared paper)Z Brzozowski (1 shared paper)
- Journals
- Journal of Medicinal Chemistry (3 papers)Bioorganic & Medicinal Chemistry Letters (2 papers)Parkinson s Disease (1 paper)Antimicrobial Agents and Chemotherapy (1 paper)Frontiers in Bioscience-Elite (1 paper)
- Partner nations
- United StatesEthiopiaPoland
In The Last Decade
Haregewein Assefa
11 papers receiving 352 citations
Peers
Comparison fields: 5 of 67
- Virology 52
- Computational Theory and Mathematics 101
- Toxicology 19
- Organic Chemistry 139
- Infectious Diseases 79
Countries citing papers authored by Haregewein Assefa
This map shows the geographic impact of Haregewein Assefa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haregewein Assefa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haregewein Assefa more than expected).
Fields of papers citing papers by Haregewein Assefa
This network shows the impact of papers produced by Haregewein Assefa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haregewein Assefa. The network helps show where Haregewein Assefa may publish in the future.
Co-authors
The 22 scholars most cited alongside Haregewein Assefa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 124 | |
| 2 | 2003 | 64 | |
| 3 | 2003 | 51 | |
| 4 | 1999 | 40 | |
| 5 | 2001 | 26 | |
| 6 | 2016 | 19 | |
| 7 | 2008 | 13 | |
| 8 | 2022 | 11 | |
| 9 | 2013 | 10 | |
| 10 | 2003 | 1 | |
| 11 | 2014 | 1 |
About Haregewein Assefa
Haregewein Assefa is a scholar working on Molecular Biology, Infectious Diseases, Computational Theory and Mathematics, Pharmacology and Oncology, having authored 11 papers that have together received 360 indexed citations. Recurring topics across this work include Computational Drug Discovery Methods (3 papers), HIV/AIDS drug development and treatment (2 papers), Cannabis and Cannabinoid Research (2 papers), HER2/EGFR in Cancer Research (2 papers), Natural product bioactivities and synthesis (2 papers), Autism Spectrum Disorder Research (1 paper), Click Chemistry and Applications (1 paper) and Pharmacological Effects of Natural Compounds (1 paper). The work is most often cited by research in Virology (52 citations), Computational Theory and Mathematics (101 citations), Toxicology (19 citations), Organic Chemistry (139 citations) and Infectious Diseases (79 citations). Haregewein Assefa has collaborated with scholars based in United States, Ethiopia and Poland. Frequent co-authors include John K. Buolamwini, Shantaram Kamath, Robert D. Sindelar, Larry Walker, Alison Nimrod, Jarosław Sławiński, Nouri Neamati, Z Brzozowski, Franciszek Sa̧czewski and Zvi G. Loewy. Their work appears in journals such as Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry Letters, Parkinson s Disease, Antimicrobial Agents and Chemotherapy and Frontiers in Bioscience-Elite.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.